In breast tumors, IL6 is secreted via CAAs, which play essential roles in favor of proliferation, angiogenesis, dissemination, invasion, and metastasis of breast cancer [62], and its production is associated with therapy resistance [63]. This evidence concerns the gene IL6 and breast carcinoma.